bromocriptine has been researched along with Demyelinative Myelitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kataria, S; Khan, E; Kramer, J; Moreno-Escobar, MC; Niaze, F; Peshwe, K; Sriwastava, S; Subedi, R; Tandon, M | 1 |
1 review(s) available for bromocriptine and Demyelinative Myelitis
| Article | Year |
|---|---|
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.
Topics: Adult; Anti-Inflammatory Agents; Bromocriptine; COVID-19; Dopamine Agonists; Humans; Male; Methylprednisolone; Myelitis, Transverse; Primary Dysautonomias; SARS-CoV-2; Spinal Cord | 2021 |